Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 stud...

por Emmanuel, A V, Kamm, M A, Roy, A J, Kerstens, R, Vandeplassche, L
Publicado 2012

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

por Kamm, M A, Lichtenstein, G R, Sandborn, W J, Schreiber, S, Lees, K, Barrett, K, Joseph, R
Publicado 2008

Diagnosis and treatment of chronic constipation – a European perspective

por Tack, J, Müller-Lissner, S, Stanghellini, V, Boeckxstaens, G, Kamm, M A, Simren, M, Galmiche, J-P, Fried, M
Publicado 2011

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

por Colombel, J-F, Schwartz, D A, Sandborn, W J, Kamm, M A, D’Haens, G, Rutgeerts, P, Enns, R, Panaccione, R, Schreiber, S, Li, J, Kent, J D, Lomax, K G, Pollack, P F
Publicado 2009

A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease

por Al-Hassi, H O, Bernardo, D, Murugananthan, A U, Mann, E R, English, N R, Jones, A, Kamm, M A, Arebi, N, Hart, A L, Blakemore, A I F, Stagg, A J, Knight, S C
Publicado 2013

Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing

por Teh, J. J., Berendsen, E. M., Hoedt, E. C., Kang, S., Zhang, J., Zhang, F., Liu, Q., Hamilton, A. L., Wilson-O’Brien, A., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A., Morrison, M.
Publicado 2021

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study

por Loayza, J.J. Jimenez, Kang, S., Schooth, L., Teh, J. J., de Klerk, A., Noon, E. K., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O’Brien, A., Trakman, G. L., Lin, W., Ching, J., Or, L., Sung, J.J.Y., Yu, J., Ng, S.C., Kamm, M.A., Morrison, M.
Publicado 2023